These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 21162800

  • 1. [Effect of telmisartan on tubulointerstitial injury and expression of PPARγ in rat renal tissue of IgA nephropathy model].
    Xing L, Bai L, Yu CY, Xie RJ.
    Zhonghua Yi Xue Za Zhi; 2010 Nov 02; 90(40):2860-3. PubMed ID: 21162800
    [Abstract] [Full Text] [Related]

  • 2. Zhen-wu-tang protects against podocyte injury in rats with IgA nephropathy via PPARγ/NF-κB pathway.
    Liu B, He Y, Lu R, Zhou J, Bai L, Zhang P, Ye S, Wu J, Liang C, Zhou Y, Zhou J.
    Biomed Pharmacother; 2018 May 02; 101():635-647. PubMed ID: 29518610
    [Abstract] [Full Text] [Related]

  • 3. Telmisartan but not valsartan inhibits TGF-beta-mediated accumulation of extracellular matrix via activation of PPARgamma.
    Yao Y, Zou R, Liu X, Jiang J, Huang Q, He Y, Li M, Wang S, Zhou J, Ma D, Xu G.
    J Huazhong Univ Sci Technolog Med Sci; 2008 Oct 02; 28(5):543-8. PubMed ID: 18846335
    [Abstract] [Full Text] [Related]

  • 4. [Study on protective effects and its mechanism of leflunomide on renal tissue in rat IgA nephropathy model].
    Tang Y, Lou TQ, Wang C, Peng H, Liu X, Tang H.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 May 02; 20(5):283-5. PubMed ID: 18471359
    [Abstract] [Full Text] [Related]

  • 5. Telmisartan exerts renoprotective actions via peroxisome proliferator-activated receptor-γ/hepatocyte growth factor pathway independent of angiotensin II type 1 receptor blockade.
    Kusunoki H, Taniyama Y, Azuma J, Iekushi K, Sanada F, Otsu R, Iwabayashi M, Okayama K, Rakugi H, Morishita R.
    Hypertension; 2012 Feb 02; 59(2):308-16. PubMed ID: 22252391
    [Abstract] [Full Text] [Related]

  • 6. Toll-like receptor 4 is involved in a protective effect of rhein on immunoglobulin A nephropathy.
    Chen X, Peng S, Zeng H, Fu A, Zhu Q.
    Indian J Pharmacol; 2015 Feb 02; 47(1):27-33. PubMed ID: 25821307
    [Abstract] [Full Text] [Related]

  • 7. Additive effect of PPAR-γ agonist and ARB in treatment of experimental IgA nephropathy.
    Lai KN, Chan LY, Guo H, Tang SC, Leung JC.
    Pediatr Nephrol; 2011 Feb 02; 26(2):257-66. PubMed ID: 21125406
    [Abstract] [Full Text] [Related]

  • 8. Advanced IgA nephropathy with impaired renal function benefits from losartan treatment in rats.
    Wang H, Fu W, Jin Z, Wang Y, Yao W, Yin P, Peng W.
    Ren Fail; 2013 Jul 02; 35(6):812-8. PubMed ID: 23751143
    [Abstract] [Full Text] [Related]

  • 9. [Effects of astragalus on renal tubulointerestitial lesions and expression of NF-kappaB and MCP-1 in renal tissues in rat experimental IgA nephropathy].
    Zhang GZ, Wu XC, Peng XJ, Yi ZW, Mo SH, Tan H.
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Apr 02; 10(2):173-8. PubMed ID: 18433541
    [Abstract] [Full Text] [Related]

  • 10. Protective effect of modified Huangqi Chifeng decoction on immunoglobulin A nephropathy through toll-like receptor 4/myeloid differentiation factor 88/nuclear factor-kappa B signaling pathway.
    Liusheng LI, Mingming Z, Meiying C, Yuan SI, Jinning Z, Bin Y, Yu Z.
    J Tradit Chin Med; 2024 Apr 02; 44(2):324-333. PubMed ID: 38504538
    [Abstract] [Full Text] [Related]

  • 11. [Regulatory effect of Astragalus membranaceus on the immune disorder in rats with IgA nephropathy].
    Peng XJ, Wu XC, Zhang GZ, Yi ZW, Zheng WM, He XJ, Mo SH, Tan H.
    Zhonghua Er Ke Za Zhi; 2008 Jan 02; 46(1):55-60. PubMed ID: 18353241
    [Abstract] [Full Text] [Related]

  • 12. Telmisartan ameliorates lipopolysaccharide-induced innate immune response through peroxisome proliferator-activated receptor-γ activation in human monocytes.
    Pang T, Benicky J, Wang J, Orecna M, Sanchez-Lemus E, Saavedra JM.
    J Hypertens; 2012 Jan 02; 30(1):87-96. PubMed ID: 22124178
    [Abstract] [Full Text] [Related]

  • 13. Precocious activation of genes of the renin-angiotensin system and the fibrogenic cascade in IgA glomerulonephritis.
    Del Prete D, Gambaro G, Lupo A, Anglani F, Brezzi B, Magistroni R, Graziotto R, Furci L, Modena F, Bernich P, Albertazzi A, D'Angelo A, Maschio G.
    Kidney Int; 2003 Jul 02; 64(1):149-59. PubMed ID: 12787405
    [Abstract] [Full Text] [Related]

  • 14. Telmisartan prevents the progression of renal injury in daunorubicin rats with the alteration of angiotensin II and endothelin-1 receptor expression associated with its PPAR-γ agonist actions.
    Arozal W, Watanabe K, Veeraveedu PT, Ma M, Thandavarayan RA, Sukumaran V, Suzuki K, Kodama M, Aizawa Y.
    Toxicology; 2011 Jan 11; 279(1-3):91-9. PubMed ID: 20888384
    [Abstract] [Full Text] [Related]

  • 15. Telmisartan inhibits vascular dysfunction and inflammation via activation of peroxisome proliferator-activated receptor-γ in subtotal nephrectomized rat.
    Toba H, Tojo C, Wang J, Noda K, Kobara M, Nakata T.
    Eur J Pharmacol; 2012 Jun 15; 685(1-3):91-8. PubMed ID: 22314223
    [Abstract] [Full Text] [Related]

  • 16. Telmisartan exerts antiatherosclerotic effects by activating peroxisome proliferator-activated receptor-γ in macrophages.
    Matsumura T, Kinoshita H, Ishii N, Fukuda K, Motoshima H, Senokuchi T, Taketa K, Kawasaki S, Nishimaki-Mogami T, Kawada T, Nishikawa T, Araki E.
    Arterioscler Thromb Vasc Biol; 2011 Jun 15; 31(6):1268-75. PubMed ID: 21474824
    [Abstract] [Full Text] [Related]

  • 17. Telmisartan inhibits vasoconstriction via PPARγ-dependent expression and activation of endothelial nitric oxide synthase.
    Yuen CY, Wong WT, Tian XY, Wong SL, Lau CW, Yu J, Tomlinson B, Yao X, Huang Y.
    Cardiovasc Res; 2011 Apr 01; 90(1):122-9. PubMed ID: 21156825
    [Abstract] [Full Text] [Related]

  • 18. [Nephrotoxicity of high- and low-osmolar contrast media: Protective role of fosinopril or telmisartan in a rat model].
    Duan SB, Zou Q, Li YJ, Peng YM, Liu FY, Wang YH, Xu XQ, Jiang WL, Liu YH, Li J.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Oct 01; 32(5):812-8. PubMed ID: 18007076
    [Abstract] [Full Text] [Related]

  • 19. [An experimental study of expression of angiotension converting enzyme 2 in myocardium and effect of telmisartan treatment in pressure-overloaded rats].
    Wang LJ, Ma H, Liao XX, He JG, Zhang WW, Tian F, Cai YM, Gu HB, Hao YH, Hu XS, Zou HM, Zhou QL.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 Apr 01; 20(4):218-22. PubMed ID: 18419956
    [Abstract] [Full Text] [Related]

  • 20. Telmisartan protects against vascular dysfunction with peroxisome proliferator-activated receptor-γ activation in hypertensive 5/6 nephrectomized rats.
    Toba H, Wang J, Ohigashi M, Kobara M, Nakata T.
    Pharmacology; 2013 Apr 01; 92(5-6):265-75. PubMed ID: 24281041
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.